Matt Karlyn

Matt Karlyn is a partner at Morrison & Foerster LLP with extensive experience in the life sciences, healthcare, and technology sectors.12 He has been practicing law for over 25 years, specializing in working with companies in the healthcare, pharmaceutical, medical device, and technology industries.25

Professional Background

Matt Karlyn is part of Morrison & Foerster's Life Sciences + Healthcare Leadership Team.1 His expertise lies in licensing and outsourcing, particularly in technology and life sciences.6 He has an MBA in addition to his legal qualifications, which he leverages in his practice.3

Notable Achievements

Legal Transactions:: Karlyn has been involved in several high-profile transactions, including:

• A $1.5 billion+ exclusive license agreement between CSPC Pharmaceutical Group Limited and Elevation Oncology, Inc.2
• A $700 million+ exclusive license agreement between CSPC Pharmaceutical Group Limited and Corbus Pharmaceutical Holdings2
• Representation of ACEA Therapeutics in a $488 million merger and acquisition transaction by Sorrento Therapeutics2
• Representation of Kindred Biosciences in a $440 million acquisition transaction by Elanco US, Inc.2

Recognition:: Karlyn was recognized as a finalist for Intellectual Property Attorney of the Year in the New England Legal Awards, 2024.2

Pro Bono Work

In 2021, Karlyn was honored for his pro bono efforts, particularly for leading Morrison & Foerster's work with Survivor Corps, a New York-based nonprofit organization.4

Public Presence

Karlyn is a national speaker on technology and the law.6 He is also active on social media, maintaining a presence on platforms like Twitter (now X).6